CSPC Pharmaceutical initiates Phase Ib trial of JMT206 injection in China
CSPC Pharmaceutical Group Limited started a Phase Ib study in China to evaluate JMT206 for weight management in adult patients, as monotherapy or with semaglutide.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
CSPC Pharmaceutical Initiates Phase IB Clinical Trial Of JMT206 Injection In China
CSPC PHARMACEUTICAL GROUP LIMITED HKEX:1093